跳至主要内容

2020.5 NDA/BLA Inspection Schedule by CFDI for NMPA

May 2020 NDA/BLA Inspection Schedule by CFDI for NMPA:

No.
Acceptance number
Company
Products
1
CXHS1800031
Simcere
d-borneol
1
CYHS1800020
Ascletis
Ravidasvir hydrochloride tablet
1
CYHS1800032
Simcere
d-borneol and edaravone Injection

评论